BackFennec Pharmaceuticals Overview
Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Target Price

See Fennec Pharmaceuticals's analyst price targets ($16) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.83

Average Target Price

$16.0035.2% upside

1 analysts in the last 4 months

High: $16 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-22H.C. Wainwright$1635.2% upsideOpen
2026-01-08Piper Sandler$1852.2% upsideOpen
2025-08-15Craig-HallumChase Knickerbocker$1418.3% upsideOpen
2024-05-15Craig-HallumChase Knickerbocker$1743.7% upsideOpen
2024-05-15H.C. WainwrightRaghuram Selvaraju$1526.8% upsideOpen
2024-04-04H.C. WainwrightRaghuram Selvaraju$1852.2% upsideOpen
2024-03-19Craig-HallumChase Knickerbocker$1852.2% upsideOpen
2022-11-22Cantor Fitzgerald$121.4% upsideOpen
2022-09-26Wedbush$1960.6% upsideOpen

Fennec Pharmaceuticals (FENC) FAQ

Fennec Pharmaceuticals (FENC) currently reports a target price of $16. Use the charts on this page to explore Fennec Pharmaceuticals's target price history and peer comparisons.

Analysts' average 12-month price target for Fennec Pharmaceuticals is $16, about 35.2% upside from the current share price of $11.83. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $16, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fennec Pharmaceuticals, and consider following FENC for alerts when major investors trade the stock.

Fennec Pharmaceuticals is classified in the Healthcare sector. On target price, it currently shows $16. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FENC with unrelated industries.